background image

AstraZeneca Clinical Trials

Find clinical trials for AstraZeneca. Search for AstraZeneca clinical trials in different cities and states across the United States.

Filter
Active & ResponsiveNew

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, Louisville KY, Seattle WA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase3, Recruiting
Active & Responsive

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Montreal
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06535607

Phase2, Recruiting
Active & Responsive

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

for
Healthy Participants, Obesity
Location: Glendale CA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07511205

Phase1, Recruiting
Active & Responsive

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

for
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV,
Location: Toronto
Sponsor: AstraZeneca

Sex: All

Age: 18

Code: NCT07509151

Phase3, Recruiting
Active & Responsive

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for
Metastatic Castration-resistant Prostate Cancer
Location: Montreal, Miami FL, Omaha NE, Newport Beach CA
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07611110

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

for
Chronic Lymphocytic Leukemia (CLL),
Location: Boston MA, Durham NC, Winston-Salem NC, Charlotte NC
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07024706

Phase2, Recruiting
New

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Kingston, Ajax, El Paso TX, Newport Beach CA
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07652658

Phase2, Recruiting
New

A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Location: Halifax, London
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07608354

Phase2, Recruiting
New

A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults

for
Healthy Participants
Location: Brooklyn MD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT07622433

Phase1, Recruiting
New

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Miami FL, South Pasadena CA
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07590934

Phase1, Phase2, Recruiting